BOLD
BOLD
NASDAQ · Biotechnology

Boundless Bio Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$1.52
+0.08 (+5.56%)
As of May 16, 2:25 AM ET ·
Analyst Consensus
Strong Sell
7
Analysts
Moderate
Coverage
Buy 0 0%
Hold 4 57%
Sell 3 43%
Price Target
Analyst Price Target +702.0% upside
Low Target $8.12
Average Target $12.19
High Target $14.26
Current Price $1.52
Current
$1.52
Target
$12.19
$8.12 $12.19 avg $14.26
Scenario Analysis
Bear Case
$8.12
434.2%
Low target
Base Case
$12.19
+702.0%
Avg target
Bull Case
$14.26
+838.2%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$1.72
-11.9% from high
52-Week Low
$0.96
+58.1% from low
Target vs 52W High
$12.19
+606.7% vs high
Next Earnings Report
May 18, 2026
1d
tomorrow
EPS Est: $-0.59
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
 Buy 43 56% $91.45 -52.6%